Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.2 USD | -0.68% |
|
-0.68% | -19.70% |
14/06 | Bristol Myers: FDA approval for treatment | CF |
13/06 | Bristol-Myers Squibb's Augtyro Gets FDA Accelerated Approval for Treatment of Solid Tumors | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.70% | 8.35TCr | |
+50.70% | 79TCr | |
+41.96% | 63TCr | |
-7.15% | 35TCr | |
+18.77% | 33TCr | |
+8.79% | 30TCr | |
+18.02% | 25TCr | |
+1.27% | 22TCr | |
+11.95% | 22TCr | |
+3.68% | 16TCr |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol-Myers Squibb Announces Strategies to Improve Access to Medicines